ACCELERON PHARMA INC Insider Trading for January 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ACCELERON PHARMA INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ACCELERON PHARMA INC for January 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 28 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Gift | G | 0.00 | 1,416 | 0 | 67,584 | 69 K to 67.6 K (-2.05 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 0.48 | 4,000 | 1,920 | 28,000 | |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | M | 5.08 | 1,600 | 8,128 | 27,896 | |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 41.60 | 1,000 | 41,600 | 19,100 | 20.1 K to 19.1 K (-4.98 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 41.70 | 400 | 16,680 | 20,100 | 20.5 K to 20.1 K (-1.95 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 41.81 | 2,486 | 103,940 | 24,004 | 26.5 K to 24 K (-9.38 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 41.23 | 1,514 | 62,422 | 22,490 | 24 K to 22.5 K (-6.31 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 0.48 | 4,000 | 1,920 | 24,004 | 20 K to 24 K (+20.00 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Sell | S | 41.78 | 1,600 | 66,848 | 20,004 | 21.6 K to 20 K (-7.41 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Buy | M | 5.08 | 1,600 | 8,128 | 21,604 | 20 K to 21.6 K (+8.00 %) |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | M | 0.40 | 12,500 | 5,000 | 0 | |
| Jan 22 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Buy | M | 0.40 | 12,500 | 5,000 | 69,000 | 56.5 K to 69 K (+22.12 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.88 | 2,438 | 14,335 | 6,961 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.08 | 1,500 | 7,620 | 6,000 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 5.28 | 1,562 | 8,247 | 12,145 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 1.80 | 500 | 900 | 2,000 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | M | 0.92 | 3,500 | 3,220 | 0 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 40.12 | 5,500 | 220,660 | 15,000 | 20.5 K to 15 K (-26.83 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.88 | 2,438 | 14,335 | 20,500 | 18.1 K to 20.5 K (+13.50 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.08 | 1,500 | 7,620 | 18,062 | 16.6 K to 18.1 K (+9.06 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 5.28 | 1,562 | 8,247 | 16,562 | 15 K to 16.6 K (+10.41 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 40.62 | 500 | 20,310 | 15,000 | 15.5 K to 15 K (-3.23 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Sell | S | 39.85 | 3,500 | 139,475 | 15,500 | 19 K to 15.5 K (-18.42 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 1.80 | 500 | 900 | 19,000 | 18.5 K to 19 K (+2.70 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Buy | M | 0.92 | 3,500 | 3,220 | 18,500 | 15 K to 18.5 K (+23.33 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 35,500 | |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 41.05 | 200 | 8,210 | 52,656 | 52.9 K to 52.7 K (-0.38 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 40.53 | 1,800 | 72,954 | 52,856 | 54.7 K to 52.9 K (-3.29 %) |
| Jan 16 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 3.88 | 2,000 | 7,760 | 54,656 | 52.7 K to 54.7 K (+3.80 %) |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 41.06 | 1,100 | 45,166 | 36,200 | 37.3 K to 36.2 K (-2.95 %) |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 40.09 | 400 | 16,036 | 37,300 | 37.7 K to 37.3 K (-1.06 %) |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 2,000 | 7,760 | 103,751 | |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 41.04 | 845 | 34,679 | 25,000 | 25.8 K to 25 K (-3.27 %) |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 40.38 | 1,155 | 46,639 | 25,845 | 27 K to 25.8 K (-4.28 %) |
| Jan 13 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 2,000 | 7,760 | 27,000 | 25 K to 27 K (+8.00 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Nader Francois | Director | Option Exercise | A | 41.20 | 576 | 23,731 | 576 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 41.20 | 4,665 | 192,198 | 4,665 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | POPS RICHARD F | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Maniatis Tom | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | George Jean | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCGUIRE TERRANCE | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | KANIA EDWIN M JR | Director | Option Exercise | A | 41.20 | 10,000 | 412,000 | 10,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Quisel John D | SVP Gen. Counsel & ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Sherman Matthew L | SVP & Chief Medical ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | A | 41.20 | 41,000 | 1,689,200 | 41,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Option Exercise | M | 3.88 | 5,000 | 19,400 | 105,751 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 39.59 | 4,300 | 170,237 | 25,000 | 29.3 K to 25 K (-14.68 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Sell | S | 38.67 | 700 | 27,069 | 29,300 | 30 K to 29.3 K (-2.33 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | MCLAUGHLIN KEVIN F | SVP, CFO and Treasu ... | Buy | M | 3.88 | 5,000 | 19,400 | 30,000 | 25 K to 30 K (+20.00 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Option Exercise | A | 41.20 | 151,000 | 6,221,200 | 151,000 | |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 39.66 | 18,800 | 745,608 | 56,500 | 75.3 K to 56.5 K (-24.97 %) |
| Jan 09 2015 | XLRN | ACCELERON PHARMA I ... | Knopf John L | CEO and President | Sell | S | 38.93 | 1,200 | 46,716 | 75,300 | 76.5 K to 75.3 K (-1.57 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Option Exercise | M | 1.80 | 5,000 | 9,000 | 6,094 | |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 39.36 | 700 | 27,552 | 52,656 | 53.4 K to 52.7 K (-1.31 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Sell | S | 38.32 | 4,300 | 164,776 | 53,356 | 57.7 K to 53.4 K (-7.46 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Ertel Steven D | SVP & Chief Busines ... | Buy | M | 1.80 | 5,000 | 9,000 | 57,656 | 52.7 K to 57.7 K (+9.50 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Option Exercise | M | 5.88 | 4,000 | 23,520 | 4,500 | |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 39.37 | 400 | 15,748 | 37,700 | 38.1 K to 37.7 K (-1.05 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Sell | S | 38.36 | 3,600 | 138,096 | 38,100 | 41.7 K to 38.1 K (-8.63 %) |
| Jan 05 2015 | XLRN | ACCELERON PHARMA I ... | Kumar Ravindra | VP & Chief Scientif ... | Buy | M | 5.88 | 4,000 | 23,520 | 41,700 | 37.7 K to 41.7 K (+10.61 %) |